Implementation Toolkit to Enhance EBP Among Marginalized Families

October 5, 2023 updated by: James Lee, Seattle Children's Hospital
Although the efficacy of early intervention (EI) for autistic children and their families has been established, many marginalized families with diverse cultural and linguistic backgrounds still report inequitable access to evidence-based practices (EBP). There are several strategies to increase EBP implementation that are especially relevant to marginalized families who report inequitable access to coaching from EI providers, such as increasing the capacity of EI providers to coach families in a culturally responsive way. However, EI providers are provided with limited professional development in both family coaching and cultural responsiveness, which results in perpetuation of EBP implementation failure. Thus, it is crucial to develop and validate an implementation toolkit that comprises strategies to enhance cultural responsiveness in the uptake of EBPs among EI providers. Therefore, the overall purpose of this research is to identify facilitators and barriers of EBP implementation among marginalized families in EI to aid the development an implementation toolkit with a focus on capacity building of EI providers to implement EBP with cultural responsiveness. This will involve conducting individual interviews with EI providers.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98115
        • Seattle Children's Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

There are two sets of inclusion criteria for both types of participants.

Inclusion Criteria for EI providers:

  • Currently working with minoritized families of young children within Part-C
  • Willing to complete I-TEAM as instructed
  • Over the age of 18

Exclusion Criteria for EI providers:

  • Not able to complete I-TEAM as instructed

Inclusion Criteria for families:

  • Having a minoritized backgrounds (e.g., migrant/refugee background, primarily speaks another language other than English at home)
  • Having a young child eligible for early intervention services

Exclusion Criteria for EI providers:

  • Not currently receiving early intervention services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Intervention group will receive access to the I-TEAM
I-TEAM is a web-based implementation toolkit that supports to enhance cultural responsiveness of EI providers in their EBP delivery with minoritized families of young autistic children
No Intervention: Waitlist control
Waitlist control group will not receive access to the I-TEAM until the Intervention group has completed the 8-week intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coaching Fidelity Scale (CFS)
Time Frame: Change from baseline at 8 weeks
CFS is an observational measure to assess coaching fidelity during an interaction between a coach and a learner
Change from baseline at 8 weeks
Cultural Self-Efficacy Scale for Early Interventionists (CSES-EI)
Time Frame: Change from baseline at 8 weeks
CSES-EI is a 32-item, self-reported measure of cultural self-efficacy of early intervention providers
Change from baseline at 8 weeks
Social Validity
Time Frame: Change from baseline at 8 weeks
We will measure acceptability and feasibility of I-TEAM
Change from baseline at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of NDBI Strategy Implementation: Caregiver Change (MONSI-CC)
Time Frame: Change from baseline at 8 weeks
MONSI-CC is an observational measure that detects changes in caregivers' use of NDBI strategies in early intervention
Change from baseline at 8 weeks
Autism-specific parenting self-efficacy
Time Frame: Change from baseline at 8 weeks
We will use this self-reported tool to assess self-efficacy of parents of young autistic children
Change from baseline at 8 weeks
Social validity
Time Frame: Change from baseline at 8 weeks
We will assess social validity, including satisfaction with their services, reports of cultural responsiveness of their providers, acceptability of early intervention among intervention recipients
Change from baseline at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2023

Primary Completion (Estimated)

February 1, 2024

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

July 9, 2023

First Submitted That Met QC Criteria

October 5, 2023

First Posted (Actual)

October 12, 2023

Study Record Updates

Last Update Posted (Actual)

October 12, 2023

Last Update Submitted That Met QC Criteria

October 5, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00004246

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism

Clinical Trials on I-TEAM

Subscribe